Bio-Techne (TECH) Restructuring Costs (2013 - 2014)
Bio-Techne's (TECH) quarterly Restructuring Costs came in at $2.4 million in Q3 2014, up 345.49% year-on-year from $532000.0 in Q3 2013, and up 345.49% quarter-over-quarter from $532000.0 in Q3 2013.
Bio-Techne (TECH) Restructuring Costs (2013 - 2014) Analysis & Trends
Bio-Techne's Restructuring Costs history runs 2 years deep, the most recent figure standing at $2.4 million for Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 2.37 Mn |
| Sep 30, 2013 | 532,000.00 |